Efficacy and risk estimation of subcutaneous mistletoe treatment (Viscum album L. Pini) in patients with non-Hodgkin's lymphoma

被引：0
|
作者：
Kuehn, J. J. [1 ]
机构：
[1] Lukas Klin, Onkol Spezialklin, CH-4144 Arlesheim, Switzerland
来源：
PHYTOMEDICINE | 2007年 / 14卷
关键词：
Non-Hodgkin's lymphoma; Viscum album Pini treatment; Risk and efficacy; Interleukin-6; Best cases;
D O I：
10.1016/j.phymed.2007.07.021
中图分类号：
Q94 [植物学];
学科分类号：
071001 ;
摘要：
21
引用
收藏
页码：27 / 27
页数：1
相关论文
共 50 条
  • [21] Efficacy of splenectomy for patients with mantle cell non-Hodgkin's lymphoma
    Yoong, Y
    Kurtin, PJ
    Allmer, C
    Geyer, S
    Habermann, TM
    Nagorney, M
    Witzig, TE
    LEUKEMIA & LYMPHOMA, 2001, 42 (06) : 1235 - 1241
  • [22] Ruxolitinib and risk of non-Hodgkin's lymphoma
    Bergeron, S.
    Bene, J.
    Wemeau, M.
    Pinel, S.
    Guihard, C.
    Peyrouzet, H.
    Gautier, S.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 64 - 65
  • [23] Romidepsin for the treatment of non-Hodgkin's lymphoma
    Yazbeck, Victor Y.
    Grant, Steven
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (07) : 965 - 979
  • [24] Advances in the treatment of non-Hodgkin's lymphoma
    Cerny, T
    Gillessen, S
    ANNALS OF ONCOLOGY, 2002, 13 : 211 - 216
  • [25] A revolution in the treatment of non-Hodgkin's lymphoma
    DeNardo, GL
    O'Donnell, RT
    Oldham, RK
    DeNardo, SJ
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 1998, 13 (04) : 213 - 223
  • [26] Bortezomib for the treatment of non-Hodgkin's lymphoma
    Bose, Prithviraj
    Batalo, Michael S.
    Holkova, Beata
    Grant, Steven
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (16) : 2443 - 2459
  • [27] A randomized comparison of the efficacy and toxicity of epirubicin and doxorubicin in the treatment of patients with non-Hodgkin's lymphoma
    Nair, R
    Ramakrishnan, G
    Nair, NN
    Saikia, TK
    Parikh, PM
    Joshi, SR
    Soman, CS
    Mukhadan, M
    Dinshaw, KT
    Advani, SH
    CANCER, 1998, 82 (11) : 2282 - 2288
  • [28] Treatment of aggressive non-Hodgkin's lymphoma
    Coiffier, B
    SEMINARS IN ONCOLOGY, 1999, 26 (05) : 12 - 20
  • [29] Rituximab in the treatment of non-Hodgkin's lymphoma
    Hauptrock, Beate
    Hess, Georg
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (04): : 619 - 633
  • [30] Zevalin™.: Treatment of non-Hodgkin's lymphoma
    Witzig, TE
    DRUGS OF THE FUTURE, 2002, 27 (06) : 563 - 568
12345